June 11, 2022
Article
In a study presented at SLEEP 2022, investigators provide an overview of the impact of obstructive sleep apnea and daytime sleepiness with increased risk of atherosclerotic cardiovascular disease.
January 26, 2022
Article
An analysis of Vaccine Adverse Event Reporting System (VAERS) data suggests three-fourths of all myocarditis cases observed in the first 8 months of COVID-19 vaccination occurred in persons 30 years and younger.
December 16, 2021
Article
A retrospective analysis of data from a Chicago School of Medicine care center provides insight into the apparent increase in risk of atrial fibrillation among patients with sickle cell disease.
September 27, 2021
Article
Announced on September 24, the approval is for use as an adjunct to diet and other LDL-C-lowering therapies for reducing LDL-C in patients aged 10 years and older with heterozygous familial hypercholesterolemia.
September 15, 2021
Video
Matthew Budoff, MD, discusses what he views as hurdles to achieving optimal prescription of newer agents in the treatment of cardiometabolic conditions, including diabetes, heart failure, dyslipidemia, and more.
April 01, 2021
Article
The US FDA has granted a second approval to treprostinil (Tyvaso) inhalation solution, this time for the treatment of patients pulmonary hypertension associated with interstitial lung disease (PH-ILD) to help improve exercise ability.